Information:
Error:
ID
15614
Description
EF5 in Measuring Tumor Hypoxia in Patients With Stage I-III Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02154399
Link
https://clinicaltrials.gov/show/NCT02154399
Keywords
Versions (1)
- 6/5/16 6/5/16 -
Uploaded on
June 5, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Stage IA Non-Small Cell Lung Carcinoma NCT02154399
Eligibility Stage IA Non-Small Cell Lung Carcinoma NCT02154399
- StudyEvent: Eligibility
Similar models
Eligibility Stage IA Non-Small Cell Lung Carcinoma NCT02154399
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
non-small cell lung cancer
Item
known or suspected non-small cell lung cancer; patients without histologically or cytologically documented non-small cell lung cancer (nsclc) must be estimated by their physician to have at least 75% probability of having nsclc; the probability of malignancy will be predicted on the basis of known probabilities of individual clinical characteristics using a bayesian model
boolean
C0007131 (UMLS CUI [1])
clinical or pathologic stage i to iii
Item
clinical or pathologic stage i to iii; patients in whom pre-surgical staging has not definitively establish stage iv disease are eligible
boolean
C0027646 (UMLS CUI [1])
tumor mass size
Item
tumor mass at least 1.5 cm in maximum diameter must be present on computed tomography (ct) scan and must be included in the planned surgical biopsy or resection
boolean
C3273930 (UMLS CUI [1,1])
C0205099 (UMLS CUI [1,2])
C0205099 (UMLS CUI [1,2])
surgical staging
Item
patient must be planning to undergo a surgical staging or treatment procedure (including mediastinoscopy, wedge resection, lobectomy, or pneumonectomy) and have the clinical and physiological status appropriate for this procedure
boolean
C0543467 (UMLS CUI [1])
performance status
Item
performance status 0-2
boolean
C1520224 (UMLS CUI [1])
bilirubin
Item
bilirubin within normal limits
boolean
C0005437 (UMLS CUI [1])
creatinine
Item
creatinine within normal limits or, if elevated, a creatinine clearance of at least 60 ml/min/m^2 (ef5 is primarily excreted via the kidney)
boolean
C0010294 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
C0373595 (UMLS CUI [2])
WBC
Item
white blood cell (wbc) > 2000/mm^3
boolean
C0023508 (UMLS CUI [1])
platelets
Item
platelets > 100,000/mm^3
boolean
C0005821 (UMLS CUI [1])
pregnancy or breast feeding
Item
pregnancy or breast feeding; a negative serum pregnancy test is required of any woman of childbearing potential prior to enrollment; pregnant women are excluded from this study; breastfeeding should be discontinued if the mother is treated with ef5
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
allergy to iv contrast dye
Item
allergy to iv contrast dye
boolean
C0020517 (UMLS CUI [1,1])
C0742795 (UMLS CUI [1,2])
C0742795 (UMLS CUI [1,2])
peripheral neuropathy
Item
history of grade iii or iv peripheral neuropathy as defined by the national cancer institute (nci) common terminology criteria (ctc)
boolean
C0031117 (UMLS CUI [1])